The essential process of dosage compensation equalizes X-chromosome gene expression between Caenorhabditis elegans XO males and XX hermaphrodites through a dosage compensation complex (DCC) that is homologous to condensin. The DCC binds to both X chromosomes of hermaphrodites to repress transcription by half. Here, we show that posttranslational modification by the SUMO (small ubiquitin-like modifier) conjugation pathway is essential for sex-specific assembly and function of the DCC on X. Depletion of SUMO in vivo severely disrupts binding of particular DCC subunits and causes changes in X-linked gene expression similar to those caused by deleting genes encoding DCC subunits. Three DCC subunits are SUMOylated, and SUMO depletion preferentially reduces their binding to X, suggesting that SUMOylation of DCC subunits is essential for robust association with X. DCC SUMOylation is triggered by the signal that initiates DCC assembly onto X. The initial step of assembly-binding of X-targeting factors to recruitment sites on X-is independent of SUMOylation, but robust binding of the complete complex requires SUMOylation. SUMOylated DCC subunits are enriched at recruitment sites, and SUMOylation likely enhances interactions between X-targeting factors and condensin subunits that facilitate DCC binding beyond the low level achieved without SUMOylation. DCC subunits also participate in condensin complexes essential for chromosome segregation, but their SUMOylation occurs only in the context of the DCC. Our results reinforce a newly emerging theme in which multiple proteins of a complex are collectively SUMOylated in response to a specific stimulus, leading to accelerated complex formation and enhanced function.
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epigenetics | chromatin | sexual dimorphism T he X chromosome-wide regulatory process called dosage compensation ensures that males (XO or XY) and females (or hermaphrodites) (XX) produce equivalent levels of X-chromosome products despite having different doses of X chromosomes. The failure to dosage-compensate is lethal. Dosage-compensation strategies differ from worms to humans, but typically a regulatory complex is targeted to the X chromosomes of one sex to regulate transcription along the entire chromosome (1-4). The molecular mechanisms by which these complexes assemble specifically onto X are not well understood. Here, we explore the role of posttranslational modification in the sex-specific assembly and function of the Caenorhabditis elegans dosage-compensation complex (DCC) on X chromosomes.
The nematode DCC binds to both X chromosomes of hermaphrodites to halve transcription of X-linked genes by reducing recruitment of RNA polymerase II (2, 5, 6) . A separate regulatory mechanism acts in both sexes to increase X-linked gene transcription so that genes on X are expressed equivalently to genes on autosomes after dosage compensation (6, 7) .
Five of the 10 DCC subunits are homologous to subunits of condensin, a protein complex required for the compaction, resolution, and segregation of chromosomes, suggesting that the DCC regulates gene expression by changing X-chromosome structure (2, 8) . Of the five DCC condensin subunits, four participate in other C. elegans condensin complexes, permitting some DCC subunits (DPY-26, DPY-28, MIX-1, XCAPG-1) to engage in other chromosome behaviors, including chromosome segregation and the regulation of crossovers between homologous chromosomes (8) (9) (10) (11) (12) (13) .
To function in dosage compensation, the condensin subunits must be recruited selectively to hermaphrodite X chromosomes by three X-chromosome targeting factors, which also participate in the DCC. SDC-2 (sex determination and dosage compensation), a 350-kDa protein with a coiled-coil domain, is the key hermaphrodite-specific factor that activates dosage compensation by triggering assembly of all DCC subunits onto X chromosomes (14) . DPY-30, a 13.5-kDa protein, is essential for the recruitment of all DCC subunits to X except SDC-2 (5). DPY-30 also participates in the MLL/COMPASS complex to promote local gene activation by facilitating the trimethylation of lysine 4 of histone H3 at the 5′ ends of genes on all chromosomes (5, 15) . SDC-3, a 250-kDa zinc-finger protein, is essential for the X recruitment of all DCC subunits except SDC-2 and DPY-30 (5). Before our current work, no factors had been found that strengthen protein interactions between condensin subunits of the DCC and X-targeting proteins, thereby facilitating high-affinity DCC binding to X chromosomes.
The DCC binds to two classes of sites on X. rex (recruitment element on X) sites recruit the DCC in an autonomous, sequence-dependent manner using DNA motifs enriched on X (16, 17) . In contrast, dox (dependent on X) sites lack a specific DNA Significance Dosage compensation equalizes X-chromosome transcription between nematode males (1X) and hermaphrodites (2X) via a dosage compensation complex (DCC) that binds hermaphrodite X chromosomes to repress transcription by half. We show that several DCC subunits are modified by the small ubiquitinlike modifier SUMO in response to the signal that triggers DCC assembly onto X. DCC assembly and function require SUMOylation. DCC subunit DUMPY-28 also acts in condensin complexes essential for chromosome segregation, but its SUMOylation is DCC-specific. We propose that specific signals trigger DCC protein SUMOylation, stimulating robust complex formation. SUMOylation facilitates distinct activities of proteins that function in multiple complexes.
motif and bind the DCC robustly only when attached to X (17) . dox sites are more prevalent (5-to 10-fold) than rex sites and, unlike rex sites, occur preferentially in promoters of expressed genes. The higher the expression level of the gene, the higher the probability of DCC binding to its promoter. Sex-specific DCC recruitment to rex sites enhances DCC binding to dox sites in cis (5). Without SDC-2, SDC-3, or DPY-30, dox sites lack robust DCC binding, but retain low-level intrinsic binding (5) .
Although DCC binding is strongly enriched on X chromosomes, DCC binding also occurs at infrequent sites on autosomes, in promoters of expressed genes (17) . dox and autosomal sites have equivalent low-level intrinsic DCC binding ability, and the higher level of DCC occupancy at dox sites compared with autosomal sites is due to their physical linkage to rex sites (5). Attachment of rex sites to an autosome increases autosomal DCC binding near the site of fusion (5, 18) .
We assessed whether posttranslational modification (PTM) of DCC subunits is critical for their assembly and high-affinity binding to X chromosomes, knowing that formation of protein complexes is often enhanced by PTMs of constituent subunits. We focused on the small ubiquitin-like modifier SUMO, because SUMOylation is essential for the viability of most eukaryotes and is central to such cellular processes as DNA repair, transcription, replication, and chromosome segregation (19) . Covalent attachment of the ∼100-amino acid SUMO peptide to lysine residues on its target substrates occurs through an enzymatic pathway related to the ubiquitin pathway but of greater simplicity and promiscuity. Unlike the ubiquitin pathway, which uses a diverse set of ligases to achieve specificity in substrate modification, the SUMO pathway uses a small set of ligases with limited specificity in vitro (20) . Higher eukaryotic genomes encode several SUMO paralogs with different functions, but C. elegans encodes only a single SUMO protein (21) . Although a minimal consensus sequence often surrounds the target lysine residue, the sequence is ubiquitous and insufficient to direct SUMOylation, making it difficult to predict targets of SUMOyation with accuracy (22) . Recognition of the SUMO modification occurs in part through a short hydrophobic SUMO-interacting motif (SIM) (23, 24) . The SIMs mediate both intramolecular SUMOylation and intermolecular protein interactions. SUMOylation can be reversed by SUMOspecific proteases, and substrate proteins exist in dynamic balance between modified and unmodified forms (25) .
In general, PTMs are highly specific for individual substrates and endow the substrates with new properties, such as a change in subcellular location or activity state. Although the SUMOylation machinery often targets a single protein and alters its binding partners and function (26) , a few examples exist in which the machinery targets several proteins of a specific complex to alter its overall function. For example, SUMOylation of septins in the bud neck of yeast promotes the disassembly of septin rings after cytokinesis (27) . SUMOylation of homologous recombination (HR) proteins upon their localization to DNA double-strand breaks (DSBs) enhances HR complex formation and accelerates DSB repair (28, 29) . The additive benefit of the concurrent SUMOylation of multiple subunits in a complex helps explain why knockdown of the SUMO pathway is more deleterious than eliminating SUMOylation of a single subunit.
We discovered that SUMOylation is essential for proper dosage compensation in C. elegans. Depletion of SUMO preferentially increases the expression of genes on X in XX embryos, resulting in strong overlap between the X-linked genes having elevated expression in dosage compensation-defective embryos and those having elevated expression in SUMO-depleted embryos. Moreover, depletion of SUMO drastically reduces Xchromosome binding of the DCC condensin subunits and the Xtargeting factor SDC-3. X binding in SUMO-depleted embryos is reduced to the low level of DCC binding typical for autosomes of wild-type embryos. In contrast, binding of the X-targeting factors SDC-2 and DPY-30 to X is not significantly altered by SUMO depletion, indicating that the first steps of DCC assembly onto X are independent of SUMOylation. The X-targeting factor SDC-3 and the condensin subunits DPY-27 and DPY-28 are then SUMOylated, and their SUMOylation is dependent on all three X-targeting factors. SUMOylated DCC subunits are enriched on X chromosomes, particularly at rex sites, and DCC subunits that participate in other condensin complexes are SUMOylated only in the context of the DCC.
We propose a model in which the initial steps of dosage compensation, the binding of X-targeting factors SDC-2 and DPY-30 to X chromosomes, occur independently of SUMOylation. DCC subunits are SUMOylated in response to the expression and X binding of SDC-2, the trigger that initiates DCC assembly onto X. Although low-level X-chromosome binding of DCC subunits can occur without SUMOylation, the SUMOylation of DCC subunits appears to enhance interactions between X-targeting factors and condensin subunits that promote robust DCC binding to X. Our results strengthen an emerging theme in which multiple proteins of a complex are collectively SUMOylated in response to a specific stimulus, leading to accelerated complex formation, stability, and enhanced function.
Results
SUMOylation Is Required for C. elegans Dosage Compensation. To determine whether posttranslational SUMOylation of DCC subunits is important for their sex-specific assembly onto X chromosomes, we first performed RNAi-mediated knockdown of smo-1, the sole C. elegans gene encoding a SUMO protein, and assessed defects in DCC localization by immunofluorescence (IF). Reduction of smo-1 mRNA caused complete embryonic lethality of both sexes and disrupted DCC association with X. In control embryos, DCC proteins have a punctate subnuclear localization pattern, reflecting their enriched binding to X chromosomes. In SUMO-depleted XX embryos, the DCC components assayed (SDC-3, DPY-27, DPY-26, and MIX-1) had a diffuse nuclear localization pattern (Fig. 1C and Fig. S1 ). X-binding defects appeared more severe for the condensin subunits DPY-26, DPY-27, and MIX-1 than for the X-targeting protein SDC-3 ( Fig. 1C and Fig. S1 ). This diffuse nuclear IF pattern in SUMO-depleted embryos suggested that proper DCC assembly onto X chromosomes requires SUMOylation of one or more cellular proteins.
If SUMOylation is required for X-chromosome gene expression, as implied by the smo-1(RNAi) experiments, significant overlap should exist between the genes exhibiting altered expression in SUMO-depleted embryos and those exhibiting altered expression in dosage compensation-defective embryos. Using Affymetrix microarrays, we compared genome-wide changes in gene expression in smo-1 RNAi-treated XX embryos, control RNAi XX embryos, and sdc-2 mutant XX embryos. As would be expected for a dosage-compensation defect, smo-1(RNAi) caused a disproportionate increase in the number of X-linked genes compared with autosomal genes having elevated expression. Of the 2,471 X-linked genes on the array, 37% (924 genes) were significantly overexpressed (P < 0.05) in SUMO-depleted embryos whereas only 17% (431 genes) were underexpressed. Conversely, more autosomal genes were underexpressed (27% of 15,466 genes) than overexpressed (10% of 15,466), a result mirroring the changes in gene expression caused by depletion of SDC-2. These changes in gene expression were unlikely caused by reduced expression of DCC-encoding genes because those genes were expressed at 0.5-to 1.0-fold their normal levels, and none is haploinsufficient.
Changes in gene expression caused by disrupting dosage compensation are positively correlated with changes caused by SUMO depletion. Of the 728 X-linked genes statistically overexpressed (P < 0.05) in sdc-2 mutant embryos, 66% were also statistically overexpressed (P < 0.05) in smo-1(RNAi) embryos (Fig. 1D) . A significant overlap was also found between X-linked genes with decreased expression in sdc-2 mutant embryos and in smo-1(RNAi) embryos. Of 64 X-linked genes with decreased expression in sdc-2 mutant embryos (P < 0.05), 83% were also significantly underexpressed in SUMO-depleted embryos.
Of 2,672 autosomal genes with reduced expression in sdc-2 mutants, 75% also had reduced expression in smo-1(RNAi) embryos. Of 642 autosomal genes with increased expression in sdc-2 mutants, 70% had increased expression in smo-1(RNAi) embryos. The significant overlap in gene-expression changes caused by depletion of SUMO or DCC subunit SDC-2 further supports an important role for SUMOylation in C. elegans dosage compensation.
In prior studies, we classified a limited set of genes on X as dosage-compensated by the stringent criteria that their total transcript level was not different between XX and XO embryos, and their expression was significantly higher in dosage compensation-defective XX embryos than in wild-type XX embryos (17) . Of 374 dosage-compensated genes, 64% were overexpressed in SUMO-depleted XX embryos, significantly more than the 37% expected by random overlap (P < 0.0001). Conversely, a limited set of genes was classified as escaping dosage compensation by the criteria that expression in XX embryos was higher than in XO embryos, and expression was not increased in dosage compensation-defective XX embryos (17) . Of 290 noncompensated genes, only 18% were significantly overexpressed in SUMOdepleted XX embryos, less than the amount expected by random overlap. Thus, reduction of SUMOylation not only disrupts the localization of the DCC to X, it also disrupts expression of genes normally regulated by the dosage-compensation process.
X-Chromosome Binding of DCC Condensin Subunits Is Severely
Reduced by Depletion of SUMO. To assess the defects in DCC binding caused by depleting SUMO, we first determined the genome-wide binding profiles of DCC condensin subunits (DPY-26, DPY-27, DPY-28, MIX-1) using chromatin immunoprecipitation reactions (IPs) with extracts from smo-1(RNAi) and control RNAi embryos followed by hybridization to tiling arrays (ChIP-chip). As predicted by our IF data, quantification of ChIP-chip experiments showed that binding of several DCC condensin subunits was severely reduced along the X chromosome, confirming that SUMOylation is essential for DCC assembly onto X (Fig. 2 A-C) . For example, 70% of X-chromosome binding sites with high DPY-27 occupancy (peak score ≥ 75) in control embryos had no or low occupancy in smo-1(RNAi) embryos. In fact, binding of DPY-27 to X in the SUMO-depleted embryos was reduced to the low level of binding typical for autosomes in control embryos (Fig.  3A) . Similar results were obtained for DPY-26 and DPY-28 (Fig.  S2A) . MIX-1 binding was affected less severely. These results indicate that robust binding of some DCC condensin subunits to X requires SUMOylation and that DCC subunits have different requirements for SUMOylation. , and CAPG-1) that are homologous to the five condensin subunits, three subunits (SDC-2, SDC-3, and DPY-30) critical for assembly of DCC subunits onto X, and two subunits (DPY-21 and SDC-1) critical for DCC activity. MIX-1 and DPY-27 are SMC proteins (structural maintenance of chromosomes) with long coiled-coil and ATPase domains. MIX-1, DPY-26, DPY-28, and CAPG-1 act in other C. elegans condensin complexes essential for chromosome segregation. DPY-30 also acts in the MLL/COMPASS complex that produces the H3K4me3 chromatin mark characteristic of activated genes. SDC-2 is the sole DCC subunit expressed exclusively in XX embryos. It confers sex specificity and X specificity to dosage compensation. (B) Sex-specific assembly of the DCC onto X chromosomes of XX embryos is controlled by a genetic pathway that regulates both sex determination and dosage compensation. sdc-2 acts with the zinc finger proteins sdc-1 and sdc-3 to induce hermaphrodite sexual development by repressing transcription of the male sex-determining gene her-1. sdc-2 acts with sdc-3 and dpy-30 to assemble the DCC onto X and thereby activate dosage compensation. Without sdc-2, the DCC cannot bind to X, causing the death of all XX embryos, and her-1 is expressed, causing masculinization of XX embryos. (C) DCC subunit DPY-27 fails to localize to the X chromosomes of XX embryos depleted of the SUMO peptide. Confocal images of XX embryos treated with control RNAi or RNAi directed against smo-1, costained with DAPI (4,6-diamidino-2-phenylindole) (red in merge) and DPY-27 antibodies (green in merge). In control XX embryos, DPY-27 exhibits a punctate localization pattern in nuclei, indicating enrichment on X chromosomes. In SUMO-depleted embryos, DPY-27 is diffusely localized throughout nuclei, suggesting incomplete DCC assembly on X. (Scale bar, 5 μm.) (D) SUMO depletion causes elevated expression of X-linked genes, like SDC-2 depletion. Venn diagram shows the overlap (yellow) in X-linked genes with elevated expression in both smo-1(RNAi) and sdc-2(y93, RNAi) XX embryos.
Although depletion of SUMO reduced DCC binding at both rex and dox sites, rex-site binding was more strongly affected than dox-site binding for all DCC condensin subunits tested (Figs. 2 A and B and 3 B and C and Fig. S3 ). For example, DPY-26 binding was nearly eliminated at 51% of rex sites and only 25% of dox sites. rex and dox sites that retained some DPY-26 binding showed substantially reduced binding (Figs. 2 A and B and 3 B and C and Fig. S3 ). The average DPY-26 ChIP-chip score at rex sites decreased from 2.25 in control embryos to 0.88 in smo-1 (RNAi) embryos, and the average score at dox sites decreased from 1.68 to 1.07. Similarly, DPY-28 and DPY-27 binding was reduced at both rex and dox sites, but more severely at rex sites (Figs. 2 A and B and 3B and Fig. S3 ). Thus, SUMOylation is most important for DCC recruitment to rex sites. Reduced binding at dox sites may be a secondary consequence of reduced binding at rex sites. Depletion of SUMO by RNAi treatment is incomplete and may contribute to some of the residual DCC binding at rex and dox sites. We assessed whether SUMOyation is critical for the X-chromosome association of factors that confer X specificity to DCC binding and initiate the assembly of DCC subunits onto X. Of the three X-targeting factors, SDC-2 is the key hermaphrodite-specific factor that triggers assembly of the DCC onto X. Unlike all other DCC subunits, which are maternally supplied to young embryos regardless of their future sex, SDC-2 is expressed exclusively in XX embryos after the hermaphrodite fate is specified (14) . SDC-2 can associate with X chromosomes without other DCC components. Once produced, SDC-2 acts in collaboration with SDC-3 and DPY-30 to initiate the sex-specific, sequence-dependent recruitment of all DCC components to rex sites (5, 16) . In contrast, DPY-30 requires SDC-2 but not other DCC subunits for its association with X, and SDC-3 requires both SDC-2 and DPY-30 (5) .
Binding of the X-targeting factors SDC-2 and DPY-30 to X chromosomes was not significantly changed in response to depletion of SUMO (Figs. 2 A-C and 3 B, E, and F and Fig. S2B ). Only small quantitative changes were detected in overall binding of SDC-2 and DPY-30 to X chromosomes in SUMO-depleted embryos, and binding to rex and dox sites was barely altered (Figs. 2 A and B and 3 B, E, and F). For SDC-2, the binding on X is greater than the binding on autosomes in smo-1(RNAi) embryos ( Fig. 2B) , as is true for all DCC subunits in control embryos. Ninety-four percent of rex sites with high SDC-2 occupancy (peak score > 0.75) in control embryos had high occupancy in SUMO-depleted embryos. The average SDC-2 ChIP-chip peak score at rex sites was 2.18 in control embryos and 2.22 in smo-1 (RNAi). dox-site binding was only minimally reduced ( Fig. 3B and Fig. S3 ). Similarly, for DPY-30, 95% of rex sites with high DPY-30 occupancy (peak score ≥ 0.75) in control embryos had high DPY-30 occupancy in SUMO-depleted embryos, and the average peak score at rex sites was 1.69 in control embryos and 1.77 in smo-1(RNAi) (Fig. 3 B and F) . Thus, the initial binding events that trigger recruitment of DCC subunits to X can occur independently of SUMOylation. Curiously, the intensity of DPY-30 binding at dox sites increased in smo-1 RNAi-treated embryos (Figs. 2B and 3B); the average score increased from 1.17 to 1.37. This increase in DPY-30 occupancy is likely due to DPY-30's dual participation in the DCC and in the MLL/COMPASS complex. The increased occupancy was not directly correlated with a change in expression of the promoters bound by DPY-30.
Binding of X-Targeting Factor SDC-3 Is Reduced by Depletion of SUMO. In contrast to SDC-2 and DPY-30, binding of SDC-3 to X chromosomes was reduced in SUMO-depleted embryos, as judged by IF and ChIP-chip experiments, although the SDC-3 binding defect was less severe than that of the DCC condensin subunits (Figs. 2 A and B and 3 B and D and Fig. S2 ). Only 30% of X-binding sites with high SDC-3 occupancy (peak score ≥ 0.75) in control embryos had low or no SDC-3 occupancy in SUMO-depleted embryos compared with 70% with high. The average score of sites with residual SDC-3 binding was reduced from 0.97 in control embryos to 0.71 in smo-1(RNAi) embryos. SDC-3 binding was nearly eliminated at 28% of rex sites and 7% of dox sites although rex and dox sites that retained SDC-3 binding had reduced average peak scores: from 1.89 to 1.23 at rex sites, and from 1.15 to 0.93 at dox sites (Fig. 3B) . For SDC-3, SUMOylation is more important for optimal binding at rex sites than dox sites (Figs. 2 A and B and 3 B and D and Fig. S3 ).
Together, our results support a model in which the initial events of dosage compensation, the binding of SDC-2 and DPY-30 to rex sites, occur independently of SUMOylation. Maximal binding of SDC-3 to rex sites and almost all binding of DCC condensin subunits to rex sites subsequently require SUMOylation.
Depletion of SUMO Increases DCC Binding on Autosomes. Analysis of ChIP-chip profiles in SUMO-depleted embryos revealed new binding sites on autosomes for all DCC subunits, both condensin subunits and X-targeting factors, sites that were not present in control embryos (Fig. 4A) . Across all autosomes, 1,535 new binding sites were detected in common between SDC-3 and DPY-27, representing a 38% increase in autosomal sites. Of these sites, 188 had high occupancy (peak score ≥ 0.75), reflecting a 23% increase in high-occupancy sites. Like dox sites on X and DCC binding sites on autosomes of control embryos, the new DCC binding sites on autosomes of SUMO-depleted embryos were strongly enriched in promoters of active genes (Fig. 4 B and C) . The greater the increase in autosomal gene expression in smo-1(RNAi) embryos, the greater the increase in DCC occupancy of all DCC subunits on autosomes ( Fig. 4C and Fig. S4 ). Whether these new DCC binding sites promote increased gene expression or result from increased gene expression is not known. Either way, SUMOylation of one or more proteins is essential not only for DCC assembly onto X chromosomes, but also for the wild-type pattern of autosomal DCC binding.
Multiple DCC Subunits Are SUMOylated. The observations that (i) the SUMO conjugation pathway is required for proper binding of several DCC subunits to X chromosomes and (ii) SUMOy- lation of proteins often promotes protein-protein interactions caused us to assess whether DCC components are SUMOylated. Using antibodies to each of the 10 DCC proteins, we performed Western blots to determine whether control embryos had higher molecular weight variants of DCC subunits than SUMO-depleted embryos ( Fig. 5 A and B and Fig. S5 ). Such higher molecular weight variants were found for three DCC subunits: SDC-3, DPY-27, and DPY-28 (Fig. 5B) . For both DPY-27 and DPY-28, the increase in molecular weight was consistent with the addition of a single SUMO molecule. For SDC-3, one and often multiple higher molecular weight variants were detected. Three lines of evidence confirmed that the higher molecular weight variants of DPY-27, DPY-28, and SDC-3 were caused by SUMO modification, rather than a SUMO-dependent modification such as ubiquitination. First, treatment of DPY-27, DPY-28, and SDC-3 immunoprecipitation reactions with a SUMOspecific protease before Western blot analysis greatly reduced the abundance of the higher molecular weight variants, indicating that DPY-27, DPY-28, and SDC-3 are SUMOylated (Fig. 5C) . Second, FLAG antibodies detected the higher molecular weight DPY-27 variant in Western blot analysis of a smo-1 deletion strain expressing an N-terminal FLAG-tagged SMO-1 molecule (Fig. 5D ). Third, a high-throughput mass-spectrometry study identified DPY-27 and DPY-28 as potential targets of SUMOylation although the sites of modification were not mapped (30) . Thus, SDC-3, DPY-27, and DPY-28 are bona fide targets of SUMOylation in XX embryos. The SUMOylated variants represented 40% (± 1.4% SEM) of total DPY-27 protein, 22% (± 5.0% SEM) of DPY-28 protein, and 31% (± 2.1% SEM) of SDC-3 protein.
Of importance, the DCC subunits that are modified by SUMO are the very components whose binding to X is most diminished by depletion of SUMO, supporting our hypothesis that SUMOylation of specific DCC components is essential for their recruitment to X. The only exception is DPY-26. The association of DPY-26 with X is dependent on DPY-27, making it likely that the severe defect in DPY-26 binding to X in SUMO-depleted embryos is a secondary consequence of reduced DPY-27 binding. The level of all 10 DCC proteins in SUMO-depleted embryos is at least 75% of the level in control embryos, indicating that reduction in protein levels is not responsible for the reduced recruitment of DCC subunits to X (Fig. S6A) .
A Subunit Shared Between the DCC and Condensin I Is SUMOylated
Only in the Context of the DCC. In embryos, DPY-28 participates in two chromosome-binding complexes, the DCC and condensin I; the latter modifies chromosome structure in preparation for mitotic chromosome segregation (11, 12) . We therefore asked whether SUMOylation of DPY-28 occurs in connection with its participation in one or both complexes. To do so, we selectively immunoprecipitated DPY-28 from either the DCC or condensin I, using antibodies specific to only one complex: DPY-27 for the DCC and SMC-4 for condensin I. Only the DPY-28 protein that was immunoprecipitated from the DCC showed evidence of SUMOylation (Fig. 5E ). and then all DPY-27-chromatin complexes within the pool of SUMOylated protein-chromatin complexes. This regime should capture SUMOylated DPY-27-chromatin complexes. Using extracts from the smo-1 deletion strain that expresses FLAG-tagged SMO-1 we performed four different ChIP-chip experiments: (i) ChIP using FLAG antibodies to determine the genome-wide binding sites for SUMOylated proteins, (ii) ChIP using FLAG antibodies followed by re-ChIP of eluted protein-chromatin complexes with DPY-27 antibodies to determine genome-wide binding sites for SUMOylated DPY-27 (referred to as DPY-27 re-ChIP experiments), (iii) ChIP using FLAG antibodies followed by re-ChIP of eluted protein-chromatin with IGG antibodies to determine background binding (referred to as IGG re-ChIP experiments, and (iv) ChIP using DPY-27 antibodies as a control to assess the efficiency of DPY-27 binding and detection in control vs. FLAG-tagged strains. The DPY-27 ChIP-chip profiles in control and FLAG-tagged SMO-1 embryos were virtually indistinguishable, indicating that the FLAG tag on SUMO did not impair DPY-27's ability to bind to X chromosomes or autosomes and be detected by ChIP. Analysis of sequential ChIP-chip experiments showed that SUMOylated DPY-27 is enriched on X chromosomes, particularly at rex sites (Fig. 6A and Fig. S7 ). Eighty-two percent (33/40) of all rex sites showed strong occupancy of FLAG-tagged SUMO in both ChIP-chip replicates using FLAG antibodies (average peak score ≥ 0.75), and 65% (26/40) of all rex sites re-ChIPed with DPY-27 antibodies out of the pool of protein-chromatin complexes first ChIPed with FLAG antibodies. For a rex site to be considered positive in the DPY-27 re-ChIP experiments, the site had to be identified in both biological replicates of the DPY-27 re-ChIP experiments, and the average DPY-27 re-ChIP peak score had to exceed, by at least 0.25, the average peak score from the two biological replicates of IGG re-ChIP experiments. All rex sites that scored positive for the DPY-27 re-ChIP experiments showed either no or dramatically reduced DCC condensin binding in SUMO-depleted embryos, consistent with SUMOylation of DPY-27 being important for binding.
Using the same criteria, 80% (40/50) of dox sites showed strong occupancy of FLAG-tagged SUMO, but only 36% (18/50) of dox sites re-ChIPed with DPY-27 antibodies. The average DPY-27 re-ChIP score for the positive rex sites was 1.32 ± 0.21 whereas that for the positive dox sites is 0.88 ± 0.13. The twotailed t test assuming unequal sample variances shows that the rex and dox sites behave statistically differently (P = 0.0008) with regard to the DPY-27 rechip experiment. These results indicate that the majority of rex sites are bound by SUMOylated DPY-27 protein, but dox-site binding by SUMOylated DPY-27 protein is less common. The high occupancy of rex sites with SUMOylated DPY-27 is consistent with rex-site binding being more strongly affected by smo-1(RNAi) than dox-site binding.
Of autosomal sites with strong FLAG-SUMO occupancy, 29.7% (121 of 408) were positive in the DPY-27 re-ChIP experiment. The average DPY-27 re-ChIP score for positive autosomal sites was 0.80 ± 0.018. For an autosomal site to be considered positive in the DPY-27 re-ChIP experiment, the site had to have strong FLAG-tagged SUMO occupancy in both ChIP-chip biological replicates (average peak score ≥ 0.75), the site had to be identified in both DPY-27 re-ChIP biological replicates, and the average DPY-27 re-ChIP peak score had to exceed, by at least 0.25, the average IGG re-ChIP peak score from both replicates.
Analysis using less stringent criteria for defining autosomal sites bound by FLAG-tagged SUMO proteins gave very similar results. Of autosomal sites identified in both FLAG ChIP replicates independent of peak score, 30% (178 of 593) were positive for DPY-27 re-ChIP using the criteria above. The average DPY-27 re-ChIP score for these positive autosomal sites was also 0.80 ± 0.02. Analysis by the two-tailed t test assuming unequal sample variances indicated that rex sites are preferentially enriched for binding of SUMO-modified DPY-27 compared with autosomal sites defined by either set of criteria (P = 0.0001), and that enrichment at dox sites is not different from that at autosomal sites (P = 0.21).
DCC SUMOylation Is Triggered by the X-Targeting Factors That
Initiate Assembly of the DCC onto X. In principle, DCC subunits could be SUMOylated before their binding to X or in conjunction with their recruitment to X. If SUMOylation of DCC subunits occurs in conjunction with X recruitment, SUMOylation should be dependent on the sex-specific targeting factors-SDC-2, SDC-3, and DPY-30-that trigger DCC assembly onto X. We assayed the genetic requirements for SUMOylation of DCC subunits by comparing Western blots of DPY-27, DPY-28, and SDC-3 proteins from extracts of control embryos and XX embryos with partially depleted X-targeting factors in strains sdc-2(y93, RNAi), sdc-3(y129, RNAi), or dpy-30(y130ts). The SUMOylated variants of DPY-27 and SDC-3 evident in control embryos were absent from the extracts made from X targeting-defective embryos ( Fig.  5F and Fig. S6B ). The SUMOylated variant of DPY-28 was reduced fourfold. The importance of X-targeting factors in establishing SUMOylation of DCC subunits is a strong indication that SUMOylation is triggered in response to DCC recruitment, by the signal that induces assembly of DCC subunits onto X chromosomes. The most plausible signal for SUMOylation of DCC subunits is the X-chromosome binding of SDC-2, the hermaphroditespecific trigger of DCC assembly, which is expressed in the zygote only after the embryo has determined its sex.
Discussion
Here, we showed that the small ubiquitin-like modifier SUMO is essential for X-chromosome dosage compensation in C. elegans. Three subunits of the DCC are SUMOylated in response to the signal that triggers sex-specific assembly of the DCC onto X chromosomes. Depletion of SUMO preferentially reduces the binding of these specific DCC subunits on X chromosomes and causes changes in X-linked gene expression similar to those caused by genetic disruption of the dosage-compensation machinery. The initial step of DCC assembly, the binding of XXspecific X-targeting factors to rex sites, occurs independently of SUMOylation and triggers SUMO modifications that promote robust DCC assembly and binding, likely by enhancing interactions between X-targeting factors and condensin subunits. Our results provide a strong indication that posttranslational modification of the DCC is critical for its function and highlight an emerging principle that the SUMO conjugation pathway targets multiple proteins of a complex in response to a specific signal to stimulate robust complex assembly, stability, and function.
SUMOylation Promotes DCC Assembly but Confers Neither Sex
Specificity nor X Specificity. Depletion of SUMO, like depletion of SDC-2, the X-targeting factor that confers X specificity and sex specificity, reduces binding of DCC condensin subunits on X to the low level of binding on autosomes in wild-type animals. Although DCC binding is reduced on X in SUMO-depleted embryos, it is increased on autosomes, unlike in sdc-2 mutants, particularly at promoters of genes exhibiting elevated expression. Both condensin subunits and X-targeting proteins bind to the new autosomal sites, and these sites have the low level of DCC occupancy characteristic of autosomal sites in wild-type animals. The level of DCC binding is positively correlated with the expression level of the gene. These findings could be interpreted to mean that SUMOylation confers sex specificity and X-chromosome specificity to DCC binding. However, neither is true. In SUMO-depleted embryos, X-chromosome binding of the Xtargeting factors SDC-2 and DPY-30 is nearly wild-type, indicating that X specificity and sex specificity is properly programmed. Furthermore, liberation of DCC subunits from X is not the cause of new autosomal binding because key X-targeting factors remain bound to X, while increasing their binding to autosomes. , 3 5 9 1 2 , 3 6 1 1 2 , 3 6 3 1 2 , 3 . SUMOylated DPY-27 is enriched at rex sites. (A) Representative profiles of rex and dox sites in the following ChIP-chip experiments using extracts from the FLAG-tagged SMO-1 strain: ChIP using DPY-27 antibodies; ChIP using FLAG antibodies; ChIP using FLAG antibodies followed by re-ChIP of eluted proteinchromatin complexes with DPY-27 antibodies; and ChIP using FLAG antibodies followed by re-ChIP of eluted protein-chromatin with IGG antibodies. SUMOylated DPY-27 is strongly enriched at rex sites but infrequently at dox sites. (B) Model for the role of SUMOylation in DCC assembly and function on X chromosomes. The initial step of DCC assembly, the binding of X-targeting factors to rex sites on X, occurs without SUMOylation and then triggers SUMOylation of DCC subunits. SUMOylation likely facilitates interactions between DCC subunits that leads to robust DCC assembly and function.
Although the sex-specific signal for DCC assembly on X is nearly normal in SUMO-depleted embryos, DCC assembly and stability are adversely affected in a manner congruent with the genetic requirements for assembly of DCC subunits onto X chromosomes. In wild-type embryos, SDC-2 binds to X without other known DCC subunits; DPY-30 requires SDC-2; SDC-3 requires both SDC-2 and DPY-30; and condensin subunits require SDC-2, DPY-30, and SDC-3 (5, 14) . In SUMO-depleted embryos, binding of SDC-2 and DPY-30 is relatively normal, binding of the X-targeting factor SDC-3, a subunit SUMOylated in wild-type embryos, is modestly reduced, and binding of condensin subunits, also SUMOylated in wild-type embryos, is severely reduced, particularly at rex sites. Binding of condensin subunits to X in SUMO-depleted embryos could be more severely impacted for two reasons: (i) SDC-3 binding to X is reduced; and (ii) interactions between condensin subunits and the residual SDC-3 bound to X are likely to be reduced.
Synergistic Action of SUMO Modification Facilitates DCC Assembly.
SUMO modifications have been shown to act synergistically to promote stable protein interactions and protein complex assembly. A notable example is the SUMOylation of multiple DNA repair proteins in response to a DNA double strand break (28, 29) . The SUMOylation facilitates the formation of a stable DNA repair complex. The importance of synergy was demonstrated by the fact that disrupting a single SUMO acceptor site on an individual protein had little or no effect on DNA repair, but blocking the SUMOylation of several repair proteins by disrupting the SUMO conjugation pathway had a strong effect on DNA repair. Functional synergy was attributed to the added effect of individual SUMO-SIM interations contributing to the stable formation of the repair complex.
The role of SUMOylation in the formation of the DCC appears to follow the paradigm of the DNA repair complex. DCC subunits have three important features that would permit SUMO modifications to act synergistically and thereby mediate robust protein interactions. The subunits have an affinity for each other without posttranslational modifications, multiple subunits of the complex are SUMOylated, and all but two subunits of the complex (SDC-1 and DPY-26) have multiple short hydrophobic SUMO-interacting motifs called SIMs that commonly mediate SUMO-dependent interactions. Similar to the repair complex, a specific signal initiates DCC SUMOylation. The production and X-chromosome binding of SDC-2 exclusively in young XX embryos triggers SUMOylation of multiple DCC subunits, likely potentiating physical interactions and DCC assembly. Although low-level X-chromosome binding of DCC condensin subunits can occur without SUMOylation, assembly of all DCC subunits onto X and robust association of the DCC with X requires SUMOylation, which only occurs once SDC-2 is expressed in the XX embryo. An important future test of this model would involve identifying the sites of SUMOylation, knocking them out, and analyzing binding of DCC subunits to X.
Specificity of SUMOylation and Effect on DCC Binding at rex, dox, and Autosomal Sites. Sequential genome-wide ChIP experiments that enriched first for chromatin bound to SUMOylated proteins and then for chromatin bound to SUMOylated DPY-27 protein showed that SUMOylated DPY-27 is preferentially enriched at rex sites compared with dox and autosomal sites. Consistent with this finding, SUMOylation appears to be of greater importance for DCC assembly and high-affinity binding at rex sites than the lower-affinity binding at dox sites because DCC binding is more severely reduced at rex sites than dox sites in SUMO-depleted embryos.
Several questions remain about the status and function of DCC SUMOylation at rex, dox, and autosomal sites. Not known is whether the preferential enrichment of SUMOylated DCC proteins at rex sites confers the higher DCC occupancy at rex sites than dox sites. Enhanced stability of SUMOylated protein complexes would contribute to better binding. Also unknown is whether rex sites, but not dox or autosomal sites, preferentially trigger SUMOylation because X-targeting factors critical for SUMOylation bind first to rex sites and initiate DCC assembly.
Psakhye and Jentsch (29) showed that specificity of the SUMOylation machinery for a protein complex is conferred by two factors: topological specificity and a highly specific trigger. Both of these conditions are met by rex sites but not dox or autosomal sites. rex sites have distinct DNA motifs that recruit the DCC in an autonomous manner, and the X-targeting factors that trigger SUMOylation have a strong preference for binding to rex sites. DCC binding at autosomal sites can occur without SDC-2 and is independent of DCC binding at rex sites (5) . If SUMOylation is stimulated solely by DCC binding at rex sites, a trigger may not exist for DCC SUMOylation at autosomal or dox sites. Moreover, if DCC SUMOylation occurs only at rex sites, the reduced DCC binding at dox sites in SUMO-depleted embryos could be the consequence of reduced binding at rex sites.
Duration of DCC SUMOylation. Not all of the SDC-3, DPY-27, and DPY-28 proteins in the cell are SUMOylated. Two explanations are likely. First, SUMOylation is a dynamic process in which conjugation enzymes add SUMO, and SUMO-specific proteases remove SUMO. SUMOylation of DCC components might be of limited duration because SUMOylaton might be required for DCC establishment but not DCC maintenance and thus no mechanism exists to maintain SUMOylation. Second, DCC SUMOylation likely occurs only in the context of DNA binding in general, or rex-site binding in particular, and not all DCC proteins are DNA bound.
Specificity of DPY-28 SUMOylation. Our immunoprecipitation experiments showed that DPY-28 is SUMOylated in the context of the DCC but not condensin I. Two interpretations are plausible. SUMOyation of DPY-28 might create one or more sites for protein interactions with other DCC subunits but not condensin I subunits, thereby enhancing DPY-28's participation in dosage compensation but not chromosome segregation. Relevant to this possibility, SUMOylation of Saccharomyces cerevisiae's condensin subunit Ycs4, the homolog of DPY-28, helps alter the subcellular location of the entire condensin complex and thereby change its functional activity. SUMOylation is essential for the anaphase-specific nucleolar localization of Ycs4 that is required for rDNA segregation. Robust ectopic induction of Ycs4 SUMOylation before anaphase is sufficient to cause premature Ycs4 nucleolar accumulation and concomitant segregation of rDNA markers (31) . Thus, in yeast, SUMOylation of Ycs4 preferentially fosters one of its cellular activities. In contrast, the more likely reason for the preferential SUMOylaton of DPY-28 in the context of the DCC is that SUMOylation occurs in response to DPY-28's recruitment to X chromosomes as part of the DCC. Consistent with this interpretation, mutations that prevent DCC localization severely reduce DPY-28 SUMOylation.
Roles for SUMOylation in C. elegans. Loss of SUMO or the SUMO conjugating enzyme UBC-9 causes embryonic lethality in both sexes, showing that SUMOylation is essential for cellular functions beyond dosage compensation (21) . Only a limited number of bona fide SUMO targets have been identified in C. elegans. SUMOylation of Polycomb group protein SOP-2, the first SUMO target identified, is required for its localization to nuclear bodies and its role in repression of Hox gene expression (32) . A large-scale proteomic screen identified potential SUMO targets (30) , and the study showed that SUMOylation of the cytoplasmic intermediate filament (cIF) protein named IFB-1 regulates cIF assembly through maintaining a cytoplasmic pool of nonpolymerized IFB-1.
Failure to do so causes defects in embryonic elongation and maintenance of muscle attachment to the cuticle. SUMOylation is also important for pharyngeal muscle development in the embryo (33) and development of the reproductive system, including morphogenesis of the vulva (34) (35) (36) . DCC SUMOylation is unique among these examples in representing SUMO modification of a protein complex.
Conclusion. Our work demonstrates the fundamental role of SUMOylation in the formation and function of an essential chromosome-wide repression complex. SUMO modification of multiple subunits in response to a DNA-bound trigger appears to facilitate protein interactions essential for complex stability and sex-specific transcriptional repression. These discoveries transform the emerging theme (29) of protein SUMOylation to enhance complex formation into a more general paradigm.
Materials and Methods
Nematode Strains. The following nematode strains were used in this study: wild-type XX (N2) strain TY125; sdc-2 partial loss-of-function strain sdc-2(y93, RNAi) XX; sdc-3 partial loss-of-function strain sdc-3(y129, RNAi) XX; dpy-30 partial loss-of-function strain TY1119, dpy-30(y130ts) XX; FLAG-tagged SUMO strain NX25, smo-1(ok359); Ex[FLAG-3xHIS-smo-1] XX; FLAG-tagged SDC-2 strain TY4573, sdc-2(y74); yEx992[flag-sdc-2 + myo2::gfp] XX.
ChIP Extracts and Reactions. Embryo extracts were prepared and ChIP experiments were performed as described previously (17) and noted in SI Materials and Methods, with the following changes. FLAG-tagged SDC-2 (TY4573) ChIP extracts were precleared with protein G Sepharose. Embryo ChIP experiments used 5 μg of antibody for anti-FLAG, DPY-26, and IGG ChIPs, and 10 μg of antibody for all other ChIPs. For sequential ChIP experiments (ChIP re-ChIP), twice the amount of embryo extract (6 mg) and antibody (10 μg) was used. The first round ChIP was eluted twice in 25 μL of 10 mM DTT for 15 min at 37°C, for a combined volume of 50 μL. This eluate was diluted to 1 mL in ChIP Wash Buffer without DTT (100 mM NaCl, 1 mM PMSF, 10 mM N-Ethylmaleimide), and the second round ChIP used the standard ChIP protocol.
ChIP-Chip Platform and Data Analysis. The platform, hybridization conditions, and data analysis for ChIP-chip experiments were described previously (17) . The reference genome was the WormBase WS180 release. Experiments were performed at least in duplicate.
Gene Expression Arrays and Data Analysis. Embryo microarray expression data from sdc-2 mutants were published previously (17) . For smo-1(RNAi) embryos, three samples were grown as for smo-1(RNAi) ChIP-chip, collected by bleaching, and frozen in 100-μL aliquots. RNA was prepared and hybridized to Affymetrix C. elegans Genome Microarrays as described previously (17) . Array normalization, analysis, and determination of expressed genes by MAS5 analysis were performed as published (17) .
SUMO Protease Experiments. For SUMO protease experiments, DCC components were immunoprecipitated as above. Before elution, IPs were washed three times with 1× SUMO protease buffer and resuspended in 40 μL of 1× SUMO protease buffer with or without 2 μL of SUMO protease (ULP1; Invitrogen; 12588-018). Reactions were performed at 20°C for 1 h while nutating. IPs were eluted by boiling in SDS PAGE buffer.
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Pferdehirt and Meyer 10.1073/pnas.1315793110 SI Materials and Methods Nematode Culture. All worms for embryo ChIP-chip analysis and microarray expression studies were first grown to high density on nematode growth (NG) agar plates with concentrated HB101 bacteria at 20°C. For RNAi control embryos, synchronous TY125 L1 larvae were spotted onto RNAi plates (NG agar with 100 μg/mL carbenicillin and 1 mM Isopropyl β-D-1-thiogalactopyranoside) with concentrated HT115 bacteria carrying an empty RNAi vector (L4440). Worms were grown for 96 h at 20°C before collecting embryos by bleaching. For smo-1(RNAi), synchronous L1 larvae were first grown on HB101 bacteria for 24 h to reach the L2/L3 stage and then transferred to RNAi plates spotted with concentrated HT115 bacteria carrying an Ahringer feeding library bacteria plasmid expressing double-stranded RNA to smo-1 (1). Worms were grown for 72 h at 20°C on smo-1(RNAi) before harvesting embryos by bleaching.
SDC-3 SDC-3 & DAPI control
smo-1(RNAi) Fig. S1 . SUMOylation is required for proper SDC-3 localization to X. Confocal images of XX embryos treated with either control (empty vector) RNAi or RNAi directed against smo-1, costained with DAPI (4,6-diamidino-2-phenylindole) (red in merge) and antibodies against SDC-3 (green in merge). In control XX embryos, SDC-3 exhibits a punctate pattern of nuclear localization, indicating proper enrichment on the X chromosome. In embryos depleted for the SUMO (small ubiquitin-like modifier) peptide, SDC-3 is more diffusely localized throughout the nucleus, indicating that it is not properly bound to X. . SUMOylated DPY-27 is enriched at rex sites. Representative profiles showing rex and dox sites from ChIP-chip experiments of the following experimental regimes using extracts from the smo-1 deletion strain expressing FLAG-tagged SMO-1: ChIP using DPY-27 antibodies as a control to assess the efficiency of DPY-27 binding and detection; ChIP using FLAG antibodies to determine the genome-wide binding sites for SUMOylated proteins; ChIP using FLAG antibodies followed by re-ChIP of eluted protein-chromatin complexes with DPY-27 antibodies to determine genome-wide binding sites for SUMOylated DPY-27; and ChIP using FLAG antibodies followed by re-ChIP of eluted protein-chromatin with IGG antibodies to determine background binding. SUMOylated DPY-27 is strongly enriched at most rex sites but mildly enriched at only some dox sites.
